
Voyager Acquisition Corp. (NASDAQ: VACH) related to its merger with Veraxa Biotech AG. Upon completion of the proposed transaction, each Voyager Class A and B ordinary share will be cancelled and exchanged for one Class A ordinary share in the combined company